Modifying disability in progressive multiple sclerosis

First Page		Document Content
Brain Immune system Immunosuppressants Carbamates Darunavir Sulfonamides Glatiramer acetate Laquinimod Antiretroviral drug Multiple sclerosis Protease inhibitors Immunology		Modifying disability in progressive multiple sclerosis Add to Reading List Source URL: download.thelancet.com Download Document from Source Website File Size: 203,46 KB Share Document on Facebook

	Issue 14 l[removed]l Disease courses in MS MSIF14 pp01 cover.indd 1 DocID: ND2B - View Document
	Active Biotech and Ipsen to present DocID: zX0H - View Document
	Modifying disability in progressive multiple sclerosis DocID: s4Ra - View Document
	Teva och Active Biotech fortsätter utvecklingen av NERVENTRA® (laquinimod) för multipel skleros efter bekräftat utlåtande från CHMP JERUSALEM, Israel & LUND, Sverige, den 23 maj, 2014 – Teva Pharmaceutical Indust DocID: 7DEW - View Document
	Clinical significance of serological biomarkers and neuropsychological performances in patients with temporal lobe epilepsy DocID: 51w4 - View Document